Pharmaceuticals

Acquiring Innovation: Merck buys Prometheus

Merck has inked another blockbuster deal, announcing its $10.8 billion acquisition of Prometheus Biosciences, Inc....

FOIA Requests Presaged the Post-Roe Fight Over Abortion...

FOIAengine:  Early Warnings from Florida AG, Judicial Watch, and the Media Florida Attorney General Ashley...

Pfizer and Moderna are FOIA Targets

FOIAengine Reveals Plaintiffs' Lawyers, Anti-Vaxxers in the Hunt When Pfizer and Moderna brought out their...

N.D. Cal. Dismisses Securities Class Action Against BioMarin...

On Thursday, the Northern District of California issued an order granting BioMarin Pharmaceutical Inc.’s...

Court Approves Short Form Complaint for Tylenol Autism,...

On Monday, U.S. District Judge Denise Cote approved a "short form" complaint for families...

DOJ Files Nationwide Lawsuit Against AmerisourceBergen and Subsidiaries...

On Friday, the United States filed a complaint against AmerisourceBergen Corporation as well...

Direct Purchasers Settle Novartis-Par Hypertension Drug Reverse Payment...

The direct purchasers in the ongoing antitrust litigation against Novartis Pharmaceuticals Corporation and Novartis...

Allergan Beats Securities Suit Related to Breast Implants’...

Judge Colleen McMahon has dismissed a class action suit against Allergan PLC for alleged...